✦ LIBER ✦

Childhood cancer and paternal exposure to lonizing radiation: Preliminary findings from the oxford survey of childhood cancers

✍ Scribed by Dr. Tom Sorahan; Penelope J. Roberts

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 749 KB
Volume: 23
Category: Article
ISSN: 0271-3586
DOI: 10.1002/ajim.4700230211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Childhood cancer and paternal exposure t

Childhood cancer and paternal exposure to ionizing radiation: A second report from the oxford survey of childhood cancers

✍ Dr. Tom Sorahan; Robert J. Lancashire; David H. Temperton; W. Peter Heighway 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Maternal occupational exposure to electr

Maternal occupational exposure to electromagnetic fields before, during, and after pregnancy in relation to risks of childhood cancers: Findings from the Oxford survey of childhood cancers, 1953–1981 deaths

✍ Tom Sorahan; Linda Hamilton; Kerry Gardiner; John T. Hodgson; J. Malcolm Harring 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## Background The concern that maternal exposure to electomagnetic fields (EMF) might be related to childhood cancer risks, particularly leukemia risks. Methods Maternal occupational data already collected as part of the Oxford Survey of Childhood Cancers have been reviewed. Information on occupat

Behaviors associated with ultraviolet ra

Behaviors associated with ultraviolet radiation exposure in a cohort of adult survivors of childhood and adolescent cancer : A Report from the Childhood Cancer Survivor Study

✍ Natasha Buchanan; Wendy Leisenring; Pauline A. Mitby; Anna T. Meadows; Leslie L. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Determination of the maximum tolerated d

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: A report from the childrens cancer study group

✍ Feig, Stephen A. ;Krailo, Mark D. ;Harris, Richard E. ;Baum, Edward ;Holcenberg, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

## Abstract An escalating‐dose trial of idarubicin, used weekly for 3 doses in combination with vincristine, prednisone, and L‐asparaginase (VPLI), to reinduce remission of childhood ALL at first bone marrow relapse was conducted by the Childrens Cancer Study Group (CCSG). The maximum tolerated dos